Approval · Notice of Compliance 2086 · 1999
TOBI: Notice of Compliance 2086
Issued February 16, 1999
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 2086
- Date
- February 16, 1999
- Company
- Pathogenisis Canada Limited
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Priority
- Therapeutic class
- Respiratory antibiotic
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| TOBI | 02239630 | Marketed |
Medicinal ingredients
- TOBRAMYCIN 60 MG per ML